Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
OTOSIC
- Development stage
- Unknown
- Lead developer
- Ind Blues Pharma
- Modality
- Small Molecules
- Administration
- Otic
01
Overview
OTOSIC is an ear drop formulation marketed in India by Ind Blues Pharma. It is positioned within the company's pediatric and general practitioner product portfolios for the treatment of otic conditions. Detailed clinical data, specific active ingredients, and pharmacological mechanisms of action for this regional product are not documented in standard public clinical trial registries or peer-reviewed scientific literature.
- Brand names
- OTOSIC
- Other names
- Otosic Ear Drop
Beyond the preview
Go deeper on OTOSIC.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Explore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Trace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Explore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Compare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Connect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on OTOSIC.